jump to navigation
jump to content
Search in Articles and Documents
generate
PDF
-Version of this page
1:
H
ome
(ALT-H)
2:
H
M
A Joint
(ALT-M)
3:
H
u
man Medicines
(ALT-U)
3.1:
H
e
ads of Agencies
(ALT-E)
3.2:
C
MDh
(ALT-C)
3.3:
M
R
I Product Index
(ALT-R)
3.4:
D
i
rectory
(ALT-I)
4:
V
eterinary Medicines
(ALT-V)
You are here:
Human Medicines
>
CMDh
>
About CMDh
> CMDh Reports
3.2.1:
Ab
o
ut CMDh
(ALT-O)
3.2.1.1:
CMDh Com
p
osition
(ALT-P)
3.2.1.2:
CMDh Ac
t
ivities
(ALT-T)
3.2.1.3:
CMDh
W
orkplan
(ALT-W)
3.2.1.4:
CMDh Report
s
(ALT-S)
3.2.1.5:
Co
n
tacts with Representative Organisations
(ALT-N)
3.2.1.6:
Transparenc
y
Measures
(ALT-Y)
3.2.1.7:
Ca
l
endar for CMDh meetings
(ALT-L)
3.2.1.8:
MRF
G
(1995-2005)
(ALT-G)
3.2.2:
Statistics
3.2.3:
Press Releases
3.2.4:
Procedural Guidance
3.2.5:
CMDh-Referrals
3.2.6:
Product Information
3.2.7:
Advice from CMDh
3.2.8:
Templates
3.2.9:
CMD Wor
k
ing Parties / Working Groups
(ALT-K)
3.2.10:
Paediatric Regulation
3.2.11:
Pharmacovigilance
3.2.12:
Q
uestions & Answers
(ALT-Q)
3.2.13:
Contact Form
3.2.14:
Contact Points
3.2.15:
What's new history
Summaries of Activities
Summary of CMDh Activities
2012
Summary of CMDh Activities
2011
Summary of CMDh Activities
2010
Summary of CMDh Activities
2009
Summary of CMDh Activities
2008
Summary of CMDh Activities
2007
Summary of CMDh Activities
2006
Summary of
MRFG
/CMDh Activities
2005
Evaluation of the functioning of the CMDh
2008 Report on the functioning of the CMDh (February 2009)
